Institutional Review Boards as Arbiters of Expanded Access to Unapproved Drugs: Time for a Change?

被引:2
|
作者
Redman, Barbara K. [1 ]
Bateman-House, Alison Shea [1 ]
机构
[1] NYU, Sch Med, 227 E 30th St,754A, New York, NY 10016 USA
关键词
institutional review boards (IRBs); regulation; compassionate use; preapproval access; ethics;
D O I
10.1177/2168479016628918
中图分类号
R-058 [];
学科分类号
摘要
Institutional review boards (IRBs) are one of the bodies charged with prospectively reviewing compassionate use, the hopefully therapeutic use of an unapproved drug in a seriously ill or dying patient who has no other treatment options. However, there are ethical issues in assigning this role to a body whose primary purpose is to review research proposals. The role of IRBs with regard to compassionate use must be examined and potentially revised.
引用
收藏
页码:515 / 516
页数:2
相关论文
共 15 条
  • [1] Institutional Review Boards as Arbiters of Expanded Access to Unapproved Drugs: Time for a Change?
    Barbara K. Redman
    Alison Shea Bateman-House
    Therapeutic Innovation & Regulatory Science, 2016, 50 : 515 - 516
  • [2] It Is Time to Professionalize Institutional Review Boards
    Lantos, John
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2009, 163 (12): : 1163 - 1164
  • [3] Institutional review boards under stress: Will they explode or change?
    Phillips, DF
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (20): : 1623 - 1626
  • [4] Expanded access to investigational drugs in psychiatry: A systematic review
    Vermeulen, Stefan F.
    Polak, Tobias B.
    Bunnik, Eline M.
    PSYCHIATRY RESEARCH, 2023, 329
  • [5] Is it time to rethink institutional review boards for the era of big data?
    Prosperi, Mattia
    Bian, Jiang
    NATURE MACHINE INTELLIGENCE, 2019, 1 (06) : 260 - 260
  • [6] Is it time to rethink institutional review boards for the era of big data?
    Mattia Prosperi
    Jiang Bian
    Nature Machine Intelligence, 2019, 1 : 260 - 260
  • [7] Improving Expanded Access in the United States: The Role of the Institutional Review Board
    Kelly McBride Folkers
    Alison Bateman-House
    Therapeutic Innovation & Regulatory Science, 2018, 52 : 285 - 293
  • [8] Improving Expanded Access in the United States: The Role of the Institutional Review Board
    Folkers, Kelly McBride
    Bateman-House, Alison
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2018, 52 (03) : 285 - 293
  • [9] Time required to review research protocols at 10 Veterans Affairs Institutional Review Boards
    Varley, Patrick R.
    Feske, Ulrike
    Gao, Shasha
    Stone, Roslyn A.
    Zhang, Sijian
    Monte, Robert
    Arnold, Robert M.
    Hall, Daniel E.
    JOURNAL OF SURGICAL RESEARCH, 2016, 204 (02) : 481 - 489
  • [10] Time, place, and consciousness: Three dimensions of meaning for US institutional review boards
    Putney, SB
    Gruskin, S
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2002, 92 (07) : 1067 - 1070